77480 Federal Register / Vol. 79, No. 247 / Wednesday, December 24, 2014 / Notices 

Agency is not proposing mitigation 

changes at this time. The risk 

assessment for lactofen did not come to 

a conclusion of ‘‘no effect’’ to listed 

species. Therefore, consultation with 

FWS on the potential risk of lactofen to 

listed species will be necessary. 

Lactofen has not been evaluated under 

EDSP. Therefore, the Agency’s final 

registration review decision is 

dependent on the results of consultation 

under ESA section 7 with FWS and the 

evaluation of potential endocrine 

disrupter risk. Pending the outcome of 

these actions, EPA is issuing an interim 

registration review decision for lactofen. 

Macleaya Extract (Interim Decision). 

The registration review docket for 

macleaya extract (EPA–HQ–OPP–2011– 

0172) opened in March 2011. Macleaya 

extract is a plant extract of Macleaya 

cordata, and is registered for use only in 

enclosed commercial greenhouses, as an 

ornamental plant fungicide for the 

control of foliar fungal diseases. There 

are no registered food uses of macleaya 

extract. EPA completed a qualitative 

draft human health risk assessment for 

all macleaya extract uses. No risks of 

concern were identified. The Agency 

did not conduct a comprehensive 

ecological risk assessment since the use 

pattern does not likely result in outdoor 

exposures. However, the Agency 

completed a qualitative endangered 

species assessment for the greenhouse 

use. No risks of concern were identified 

and the Agency has made a ‘‘no effect’’ 

determination for federally listed 

species and designated critical habitat. 

Macleaya extract has not been evaluated 

under the EDSP. Therefore, the 

Agency’s final registration review 

decision is dependent upon the result of 

the evaluation of potential endocrine 

disruptor risk. The EPA is issuing an 

interim registration review decision for 

macleaya extract. 

Trinexapac-ethyl (Interim Decision) 

The registration review docket for 

trinexapac-ethyl (EPA–HQ–OPP–2008– 

0657) opened in a notice published in 

the Federal Register of September 15, 

2008 (73 FR 53244) (FRL–8381–3). 

Trinexapac-ethyl is a plant growth 

regulator registered for use by 

homeowners and professional 

applicators to manage growth of barley, 

grasses grown for seed, oats, sugarcane, 

triticale, turf grass, and wheat. Turf 

grass uses include athletic fields and 

parks, commercial and residential 

lawns, golf courses, and sod farms. It is 

also registered for application around 

flower beds, ornamental trees, and 

shrubs. EPA conducted a human health 

risk assessment and did not identify any 

risks of concern. In addition, EPA 

conducted an ecological risk 

assessment. Based on low risk estimates, 

and the conservative nature of the risk 

assessment, the Agency does not 

anticipate ecological risks of concern for 

assessed taxa from currently registered 

uses of trinexapac-ethyl. The Agency is 

not proposing mitigation changes at this 

time. However, the Agency is proposing 

that labels clarify the single-maximum 

application rate for liquid turf end-use 

products. Two comments were received 

for the trinexapac-ethyl proposed 

interim decision on the detail of the risk 

assessment. These comments did not 

change the interim decision. The risk 

assessment for trinexapac-ethyl did not 

come to a conclusion of ‘‘no effect’’ to 

listed species. Therefore, consultation 

with the Services on the potential risk 

of trinexapac-ethyl to listed species will 

be necessary. Trinexapac-ethyl has not 

been evaluated under EDSP. Therefore, 

the Agency’s final registration review 

decision is dependent on the result of 

consultation under ESA section 7 with 

FWS and the evaluation of potential 

endocrine disrupter risk. Pending the 

outcome of these actions, EPA is issuing 

an interim registration review decision 

for trinexapac-ethyl. 

Quizalofop (Interim Decision). The 

registration review docket for quizalofop 

(EPA–HQ–OPP–2007–1089) opened in 

2007. Quizalofop is a selective postemergence herbicide and appears as two 

different isomers: quizalofop-ethyl and 

quizalofop-p-ethyl. Quizalofop-ethyl is a 

50/50 racemic mixture of R- and Senantiomers and there are no active 

pesticide registrations of this isomer. 

Quizalofop-p-ethyl is the purified Renantiomer and the pesticidally active 

isomer. For the Agency’s purposes, both 

isomers will be referred to collectively 

as quizalofop. Quizalofop is registered 

to control annual and perennial grasses 

in various crops including Chinese 

cabbage, cotton, garlic, grains, legumes, 

mint, pineapple, soybean, sugar beets, 

and sunflower. Quizalofop is also used 

in non-agricultural settings, such as 

cottonwood and poplar plantations, 

fencerows, roadsides, and other 

uncultivated areas. EPA conducted a 

risk assessment for both human health 

and ecological risk. No risks of concern 

were identified in the human health risk 

assessment. The ecological risk 

assessment indicated potential risks to 

amphibians, freshwater fish, non-target 

monocots, and terrestrial mammals. The 

Agency will modify the application 

directions for quizalofop to reduce spray 

drift risk to non-target organisms. The 

screening-level endangered species 

assessment did not come to a 

conclusion of ‘‘no effect’’ to listed 

species, therefore, consultation with 

FWS on the potential risk of quizalofop 

to listed species will be necessary. 

Quizalofop has not been evaluated 

under EDSP. Therefore, the Agency’s 

final registration review decision is 

dependent on the result of consultation 

under ESA section 7 with FWS and the 

evaluation of potential endocrine 

disruptor risk. Pending the outcome of 

these actions, EPA is issuing an interim 

registration review decision for 

quizalofop. 

Pursuant to 40 CFR 155.58(c), the 

registration review case docket for 4- 

CPA (Case 2115), Allethrins (Case 0473), 

Clofentezine (Case 7602), Cyromazine 

(Case 7439), Fosthiazate (Case 7604), 

Hexythiazox (Case 7404), Lactofen (Case 

7210), Macleaya Extract (Case 7024), 

Trinexapac-ethyl (Case 7228), and 

Quizalofop (Case 7215) will remain 

open until all actions required in the 

final/interim decision have been 

completed. 

Background on the registration review 

program is provided at: http://www.epa.

gov/oppsrrd1/registration_review. Links 

to earlier documents related to the 

registration review of this pesticide are 

provided at: http://www2.epa.gov/

pesticide-reevaluation/individualpesticides-registration-review. 

Authority: 7 U.S.C. 136 et seq. 

Dated: December 16, 2014. 

Richard P. Keigwin, Jr., 

Director, Pesticide Re-Evaluation Division, 

Office of Pesticide Programs. 

[FR Doc. 2014–30214 Filed 12–23–14; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPP–2014–0814; FRL–9919–24] 

Registration Review Proposed Interim 

Decisions; Notice of Availability 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: This notice announces the 

availability of EPA’s proposed interim 

registration review decisions and opens 

a public comment. Registration review 

is EPA’s periodic review of pesticide 

registrations to ensure that each 

pesticide continues to satisfy the 

statutory standard for registration, that 

is, that the pesticide can perform its 

intended function without unreasonable 

adverse effects on human health or the 

environment. Through this program, 

EPA is ensuring that each pesticide’s 

registration is based on current 

scientific and other knowledge, 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 79, No. 247 / Wednesday, December 24, 2014 / Notices 77481 

including its effects on human health 

and the environment. 

DATES: Comments must be received on 

or before February 23, 2015. 

ADDRESSES: Submit your comments, 

identified by docket identification (ID) 

number for the specific pesticide of 

interest provided in the table in Unit 

II.A., by one of the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the online 

instructions for submitting comments. 

Do not submit electronically any 

information you consider to be 

Confidential Business Information (CBI) 

or other information whose disclosure is 

restricted by statute. 

• Mail: OPP Docket, Environmental 

Protection Agency Docket Center (EPA/ 

DC), (28221T), 1200 Pennsylvania Ave. 

NW., Washington, DC 20460–0001. 

• Hand Delivery: To make special 

arrangements for hand delivery or 

delivery of boxed information, please 

follow the instructions at http://www.

epa.gov/dockets/contacts.html. 

Additional instructions on commenting 

or visiting the docket, along with more 

information about dockets generally, is 

available at http://www.epa.gov/

dockets. 

FOR FURTHER INFORMATION CONTACT: For 

pesticide specific information, contact: 

The Chemical Review Manager for the 

pesticide of interest identified in the 

table in Unit II.A. 

For general information on the 

registration review program, contact: 

Richard Dumas, Pesticide Re-Evaluation 

Division (7508P), Office of Pesticide 

Programs, Environmental Protection 

Agency, 1200 Pennsylvania Ave. NW., 

Washington, DC 20460–0001; telephone 

number: (703) 305–8015; email address: 

dumas.richard@epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

This action is directed to the public 

in general, and may be of interest to a 

wide range of stakeholders including 

environmental, human health, farm 

worker, and agricultural advocates; the 

chemical industry; pesticide users; and 

members of the public interested in the 

sale, distribution, or use of pesticides. 

Since others also may be interested, the 

Agency has not attempted to describe all 

the specific entities that may be affected 

by this action. If you have any questions 

regarding the applicability of this action 

to a particular entity, consult the 

Chemical Review Manager for the 

pesticide of interest identified in the 

table in Unit II.A. 

B. What should I consider as I prepare 

my comments for EPA? 

1. Submitting CBI. Do not submit this 

information to EPA through 

regulations.gov or email. Clearly mark 

the part or all of the information that 

you claim to be CBI. For CBI 

information in a disk or CD–ROM that 

you mail to EPA, mark the outside of the 

disk or CD–ROM as CBI and then 

identify electronically within the disk or 

CD–ROM the specific information that 

is claimed as CBI. In addition to one 

complete version of the comment that 

includes information claimed as CBI, a 

copy of the comment that does not 

contain the information claimed as CBI 

must be submitted for inclusion in the 

public docket. Information so marked 

will not be disclosed except in 

accordance with procedures set forth in 

40 CFR part 2. 

2. Tips for preparing your comments. 

When preparing and submitting your 

comments, see the commenting tips at 

http://www.epa.gov/dockets/

comments.html. 

II. What action is the Agency taking? 

Pursuant to 40 CFR 155.58, this notice 

announces the availability of EPA’s 

proposed interim registration review 

decisions for the pesticides shown in 

the following Table, and opens a 60-day 

public comment period on the proposed 

interim decisions. 

TABLE—REGISTRATION REVIEW PROPOSED INTERIM DECISIONS

Registration review case name and 

No. Pesticide docket ID No. Chemical review manager, telephone number, email address 

Acetic acid and sodium diacetate 

(Case 4001).

EPA–HQ–OPP–2008–0016 Carolyn Schroeder, (703) 308–2961, schroeder.carolyn@epa.gov. 

Fosetyl-Al (Case 0646) .................... EPA–HQ–OPP–2007–0379 Ricardo Jones, (703) 347–0493, jones.ricardo@epa.gov. 

Picaridin (Case 7433) ...................... EPA HQ–OPP–2014–0341 Ricardo Jones, (703) 347–0493, jones.ricardo@epa.gov. 

Sodium fluoride (NaF) (Case 3132) EPA–HQ–OPP–2014–0655 SanYvette Williams, (703) 305–7702, williams.sanyvette@epa.gov. 

Yellow mustard seed (Case 7618) 

and Sulfonic acid salts (Case 

7619).

EPA–HQ–OPP–2014–0762 Roy Johnson, (703) 347–0492, johnson.roy@epa.gov. 

1. Acetic acid and sodium diacetate. 

Acetic acid (Proposed Interim Decision). 

The registration review docket for acetic 

acid and sodium diacetate (EPA–HQ– 

OPP–2008–0016) opened in March 

2008. Acetic acid and sodium diacetate 

are two different active ingredients: 

Sodium diacetate is a salt of acetic acid. 

Acetic acid is used as a preservative for 

post harvest stored grains and hay 

intended for livestock feed. 

Additionally, it is also applied as a nonselective herbicide for control of 

broadleaf weeds and weed grasses. 

Sodium diacetate is a fungicide and 

bactericide registered to control molds 

and bacteria. It is applied to hay to 

prevent spoilage and to silage as an aid 

in fermentation. EPA published the 

Final Work Plan in August 2008. The 

Agency determined that previous 

human health assessments for acetic 

acid and sodium diacetate were 

sufficient for registration review and no 

human health risks of concern were 

identified. The Agency completed a 

comprehensive ecological risk 

assessment for the nonselective 

herbicide use of acetic acid, including 

an endangered species assessment, and 

a qualitative ecological risk assessment 

for sodium diacetate. The Agency 

concludes a ‘‘no effect’’ determination 

for acetic acid used as a nonselective 

herbicide and all currently registered 

uses of sodium diacetate for all nontarget organisms; no mitigation 

measures regarding ecological effects are 

included in the proposed interim 

decision. The risk assessments and 

proposed interim decision for acetic 

acid and sodium diacetate are currently 

available in the docket for public 

comment. Acetic acid and sodium 

diacetate have not been evaluated under 

the EDSP. Therefore, the Agency’s final 

registration review decision is 

dependent upon the results of the 

evaluation of acetic acid and sodium 

diacetate as potential endocrine 

disruptor risks. Pending the outcome of 

mstockstill on DSK4VPTVN1PROD with NOTICES

77482 Federal Register / Vol. 79, No. 247 / Wednesday, December 24, 2014 / Notices 

this action, EPA is planning to issue an 

interim registration review decision for 

acetic acid and sodium diacetate. 

2. Fosetyl-Al. Fosetyl-Al (Proposed 

Interim Decision). The registration 

review docket for fosetyl-Al (EPA–HQ– 

OPP–2007–0379) opened in December 

2007. Fosetyl-Al is systemic fungicide 

used to control diseases caused by 

oomycetes such as downy mildews. It is 

registered for use on agricultural crops 

as well as residential and commercial 

areas. EPA published draft human 

health and ecological risk assessments 

in March 2014. There are no human 

health risks of concern. The Agency also 

completed an ecological risk 

assessment. The results of this 

quantitative risk assessment indicates 

that the currently labeled rates of 

fosestyl-Al pose a potential for adverse 

effects, i.e., risk, to non-target terrestrial 

animals, including insects, birds, 

reptiles, terrestrial-phase amphibians 

and mammals. In addition, applications 

may impact sensitive species of 

dicotyledenous plants (dicots) in 

terrestrial habitats. In order to address 

potential ecological risks, the Agency is 

proposing changes to product labels 

which incorporate certain risk 

mitigation measures meant to reduce 

these risks. These measures include 

restricting aerial application of fosetylAl for certain uses, reducing the total 

number of applications that can be 

made annually for certain uses, and 

clarifying labels to better define how 

fosetyl-Al may be applied. The Agency 

completed a screening-level endangered 

species assessment and made a ‘‘no 

effects’’ determination for the following 

taxa: Fish, aquatic-phase amphibians, 

aquatic invertebrates, aquatic plants, 

and monocot plants. For all other 

species the effects determinations are 

uncertain. Fosetyl-Al has not been 

evaluated under the Endocrine 

Disruptor Screening Program (EDSP) nor 

has it completed the Endangered 

Species Act (ESA) Section 7 

consultation with the U.S. Fish and 

Wildlife Service (Service). Therefore, 

the Agency’s final registration review 

decision is dependent upon the result of 

the evaluation of potential endocrine 

disruptor risk and consultation with the 

Service for endangered species. Pending 

the outcome of these actions, EPA is 

planning to issue an interim registration 

review decision for fosetyl-Al. 

3. Picaridin. (Combined Work Plan, 

Preliminary Risk Assessments, and 

Proposed Interim Decision). The 

registration review docket for Picaridin 

(EPA HQ–OPP–2014–0341) is opening 

for public comment on a Combined 

Preliminary Work Plan, Final Work 

Plan, Preliminary Risk Assessments, 

and Proposed Interim Decision for 

registration review. Due to the lack of 

need for additional data to support this 

decision, the Agency is also issuing 

Preliminary Ecological and Human 

Health Risk Assessments for picaridin 

and opening them for public comment. 

Picaridin is a broad-spectrum insect 

repellant registered for use against 

biting flies, chiggers, fleas, mosquitos 

and ticks. Picaridin is labelled for use 

on human skin, clothing, footwear, and 

on horses. EPA has completed 

comprehensive draft human health and 

ecological risk assessments, including a 

screening-level endangered species 

assessment, for all picaridin uses. For 

human health, only residential exposure 

was assessed, and the Agency has not 

identified any risk concerns associated 

with the registered uses of picaridin. 

Due to its use on human skin and 

clothing, exposure to terrestrial nontarget organisms and plants is expected 

to be inconsequential. Based on the lack 

of potential exposure and nontoxic 

effects, the ecological risk assessment 

has made a ‘‘no effect’’ determination 

for all federally listed species and ‘‘no 

habitat modification’’ of any designated 

critical habitat for listed species. 

Picaridin has not been evaluated under 

the EDSP. Therefore, the agency’s final 

registration review decision is 

dependent upon the result of the 

evaluation of potential endocrine 

disruptor risk. Pending the outcome of 

this action, the Agency is planning to 

issue an interim registration review 

decision for picaridin. 

4. Sodium fluoride. (Combined 

Preliminary Work Plan and Proposed 

Interim Decision). The registration 

review docket for sodium fluoride 

(EPA–HQ–OPP–2014–0655) is opening 

for public comment on a Combined 

Preliminary Work Plan and Proposed 

Interim Decision. Sodium fluoride is 

registered for use as a wood preservative 

to protect the groundline portion of 

existing wooden utility poles. It is 

formulated as an impregnated pole wrap 

material. This use is not expected to 

result in direct or indirect dietary (food) 

or drinking water exposure. 

Occupational and residential exposure 

is minimal by the dermal and inhalation 

routes so no assessment is needed. 

Based on the lack of potential exposure 

and nontoxic effects to fish, aquatic 

invertebrates and birds, the ecological 

risk assessment has made a ‘‘no effect’’ 

determination for Federally listed 

species and designated critical habitat. 

Sodium fluoride has not been evaluated 

under the EDSP. Therefore, the agency’s 

final registration review decision is 

dependent upon the result of the 

evaluation of potential endocrine 

disruptor risk. Pending the outcome of 

this action, EPA is planning to issue a 

combined preliminary work plan and 

interim registration review decision for 

sodium fluoride. 

5. Yellow mustard seed/Sulfonic acid 

salts (Combined Preliminary Work Plan 

and Proposed Interim Decision). The 

registration review docket for yellow 

mustard seed and sulfonic acid salts is 

opening for public comment on a 

Combined Preliminary Work Plan and 

Proposed Interim Decision. The 

registration review docket for Yellow 

Mustard Seed/Sulfonic Acid Salts 

(YMS/SAS) is opening for public 

comment on a combined Work Plan, 

Draft Risk Assessments, and a Proposed 

Interim Registration Review Decision. 

This product is a rodenticide for the 

control of the Richardson’s ground 

squirrel and Wyoming ground squirrel. 

YMS/SAS is applied by injection under 

pressure as a foam into burrows 

inhabited by the pest species in 

rangeland, ornamental plantings, 

orchards, golf courses, parks, nurseries, 

and non-crop rights-of-way. No risks of 

concern were identified. YMS/SAS have 

not been evaluated under the EDSP, nor 

has an endangered species assessment 

been conducted. The Agency’s final 

registration review decision is 

dependent upon the results of both 

assessments. Pending the outcome of 

those assessments, EPA is issuing an 

interim registration review decision for 

YMS/SAS. 

The registration review docket for a 

pesticide includes earlier documents 

related to the registration review of the 

case. For example, the review opened 

with a Summary Document, containing 

a Preliminary Work Plan, for public 

comment. A Final Work Plan was 

placed in the docket following public 

comment on the initial docket. The 

documents in the dockets describe 

EPA’s rationales for conducting 

additional risk assessments, as well as 

the Agency’s subsequent risk findings 

and consideration of possible risk 

mitigation measures. A proposed 

registration review decision will be 

supported by the rationales included in 

those documents. Following public 

comment on a proposed decision, the 

Agency will issue an interim 

registration review decision. 

The registration review program is 

being conducted under congressionally 

mandated time frames, and EPA 

recognizes the need both to make timely 

decisions and to involve the public. 

Section 3(g) of the Federal Insecticide, 

Fungicide, and Rodenticide Act (FIFRA) 

(7 U.S.C. 136a(g)) required EPA to 

establish by regulation procedures for 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 79, No. 247 / Wednesday, December 24, 2014 / Notices 77483 

reviewing pesticide registrations, 

originally with a goal of reviewing each 

pesticide’s registration every 15 years to 

ensure that a pesticide continues to 

meet the FIFRA standard for 

registration. The Agency’s final rule to 

implement this program was issued in 

August 2006 and became effective in 

October 2006, and appears at 40 CFR 

part 155, subpart C. The Pesticide 

Registration Improvement Act of 2003 

(PRIA) was amended and extended in 

September 2007. FIFRA, as amended by 

PRIA in 2007, requires EPA to complete 

registration review decisions by October 

1, 2022, for all pesticides registered as 

of October 1, 2007. 

The registration review final rule at 40 

CFR 155.58(a) provides for a minimum 

60-day public comment period on all 

proposed interim registration review 

decisions. This comment period is 

intended to provide an opportunity for 

public input and a mechanism for 

initiating any necessary amendments to 

the proposed interim decision. All 

comments should be submitted using 

the methods in ADDRESSES, and must be 

received by EPA on or before the closing 

date. These comments will become part 

of the docket for the pesticides included 

in the table in Unit II.A. Comments 

received after the close of the comment 

period will be marked ‘‘late.’’ EPA is not 

required to consider these late 

comments. 

The Agency will carefully consider all 

comments received by the closing date 

and will provide a ‘‘Response to 

Comments Memorandum’’ in the docket 

as appropriate. The final registration 

review decision will explain the effect 

that any comments had on the decision. 

Background on the registration review 

program is provided at: http://www2.

epa.gov/pesticide-reevaluation. 

Information regarding earlier documents 

related to the registration review of 

these pesticides can be found at: http:// 

www2.epa.gov/pesticide-reevaluation/

individual-pesticides-registrationreview. 

Authority: 7 U.S.C. 136 et seq. 

Dated: December 17, 2014. 

Richard P. Keigwin, Jr., 

Director, Pesticide Re-Evaluation Division, 

Office of Pesticide Programs. 

[FR Doc. 2014–30088 Filed 12–23–14; 8:45 am] 

BILLING CODE 6560–50–P 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPP–2014–0807; FRL–9919–06] 

Registration Review; Draft Human 

Health and Ecological Risk 

Assessments; Notice of Availability 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: This notice announces the 

availability of EPA’s draft human health 

and ecological risk assessments for the 

registration reviews of bentazon, 

daminozide, and d-limonene and opens 

a public comment period on these 

documents. Registration review is EPA’s 

periodic review of pesticide 

registrations to ensure that each 

pesticide continues to satisfy the 

statutory standard for registration, that 

is, the pesticide can perform its 

intended function without unreasonable 

adverse effects on human health or the 

environment. As part of the registration 

review process for each case, the 

Agency has drafted a human health and 

ecological risk assessment for all uses of 

the previously listed pesticide 

chemicals. The ecological risk 

assessment includes or will include an 

assessment of risks to listed species, and 

the human health and ecological risk 

assessments includes or will include a 

determination of endocrine disrupter 

effects for the case. After reviewing 

comments received during the public 

comment period, EPA may issue revised 

risk assessments, explain any changes to 

the draft risk assessments, and respond 

to comments. The Agency also will 

request public input on any proposed 

risk mitigation measures before 

completing proposed registration review 

decisions for the previously listed 

pesticide chemicals. Through this 

program, EPA is ensuring that each 

pesticide’s registration is based on 

current scientific and other knowledge, 

including its effects on human health 

and the environment. 

DATES: Comments must be received on 

or before February 23, 2015. 

ADDRESSES: Submit your comments, 

identified by docket identification (ID) 

number EPA–HQ–OPP–2014–0807, by 

one of the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the online 

instructions for submitting comments. 

Do not submit electronically any 

information you consider to be 

Confidential Business Information (CBI) 

or other information whose disclosure is 

restricted by statute. 

• Mail: OPP Docket, Environmental 

Protection Agency Docket Center (EPA/ 

DC), (28221T), 1200 Pennsylvania Ave. 

NW., Washington, DC 20460–0001. 

• Hand Delivery: To make special 

arrangements for hand delivery or 

delivery of boxed information, please 

follow the instructions at http://www.

epa.gov/dockets/contacts.html. 

Additional instructions on 

commenting or visiting the docket, 

along with more information about 

dockets generally, is available at http:// 

www.epa.gov/dockets. 

FOR FURTHER INFORMATION CONTACT: For 

pesticide specific information contact: 

Chemical Review Manager identified in 

the table in Unit III.A. for the pesticide 

of interest. 

For general questions on the 

registration review program, contact: 

Richard Dumas, Pesticide Re-Evaluation 

Division (7508P), Office of Pesticide 

Programs, Environmental Protection 

Agency, 1200 Pennsylvania Ave. NW., 

Washington, DC 20460–0001; telephone 

number: (703) 305–8015; email address: 

dumas.richard@epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

This action is directed to the public 

in general, and may be of interest to a 

wide range of stakeholders including 

environmental, human health, farm 

worker, and agricultural advocates; the 

chemical industry; pesticide users; and 

members of the public interested in the 

sale, distribution, or use of pesticides. 

Since others also may be interested, the 

Agency has not attempted to describe all 

the specific entities that may be affected 

by this action. If you have any questions 

regarding the applicability of this action 

to a particular entity, consult the 

Chemical Review Manager listed under 

FOR FURTHER INFORMATION CONTACT. 

B. What should I consider as I prepare 

my comments for EPA? 

1. Submitting CBI. Do not submit this 

information to EPA through 

regulations.gov or email. Clearly mark 

the part or all of the information that 

you claim to be CBI. For CBI 

information in a disk or CD–ROM that 

you mail to EPA, mark the outside of the 

disk or CD–ROM as CBI and then 

identify electronically within the disk or 

CD–ROM the specific information that 

is claimed as CBI. In addition to one 

complete version of the comment that 

includes information claimed as CBI, a 

copy of the comment that does not 

contain the information claimed as CBI 

must be submitted for inclusion in the 

public docket. Information so marked 

will not be disclosed except in 

mstockstill on DSK4VPTVN1PROD with NOTICES